Literature DB >> 11024425

Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan.

Y Mashima1, S Yamamoto, Y Inoue, M Yamada, M Konishi, H Watanabe, N Maeda, Y Shimomura, S Kinoshita.   

Abstract

PURPOSE: To evaluate the incidence of BIGH3 gene mutations in 164 unrelated Japanese patients with corneal stromal dystrophies with an autosomal dominant trait.
METHODS: Data were collected at two major institutions in the eastern and western parts of Japan, where molecular genetic analysis was performed for diagnostic purpose.
RESULTS: The incidence of mutations was ranked as follows: 118 patients (72%), the R124H mutation associated with Avellino corneal dystrophy; 23 patients (14%), the R124C mutation associated with lattice corneal dystrophy type 1; and 10 patients (6%), the P501T mutation associated with lattice corneal dystrophy type 3A.
CONCLUSION: Avellino corneal dystrophy associated with the R124H mutation is the most common form of corneal stromal dystrophy in Japan. This dystrophy, which is diagnosed histopathologically, has also been called granular corneal dystrophy in Japan. The classification of these diseases according to genetic pathogenesis may be more appropriate than is the use of clinical or histological findings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024425     DOI: 10.1016/s0002-9394(00)00571-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  29 in total

1.  Chinese family with atypical granular corneal dystrophy type I caused by the typical R555W mutation in TGFBI.

Authors:  Su-Juan Zhao; Ya-Nan Zhu; Xing-Chao Shentu; Qi Miao
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Homozygous mutation (L527R) of TGFBI in an individual with lattice corneal dystrophy.

Authors:  N Yamada; T-I Chikama; N Morishige; R Yanai; T Nishida; M Inui; K Seki
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

3.  TGFBI gene mutation analysis in a Chinese pedigree of Avellino corneal dystrophy.

Authors:  Ai-Rui Xie; Su-Ping Cai; Yin Yang; Yin-Chuan Fan; Wen-Han Yu; Li-Heng Guo; Qiao-Na Yang; Jin Zhu; Xu-Yang Liu
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

4.  A clinical and molecular-genetic analysis of Chinese patients with lattice corneal dystrophy and novel Thr538Pro mutation in the TGFBI (BIGH3) gene.

Authors:  Ping Yu; Yangshun Gu; Yuehong Yang; Xiaoyi Yan; Lili Chen; Zhen Ge; Ming Qi; Jianmin Si; Lei Guo
Journal:  J Genet       Date:  2006-04       Impact factor: 1.166

5.  A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai family with lattice corneal dystrophy type I.

Authors:  La-Ongsri Atchaneeyasakul; Binoy Appukuttan; Sarinee Pingsuthiwong; Pa-Thai Yenchitsomanus; Adisak Trinavarat; Chatchawan Srisawat
Journal:  Jpn J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.447

6.  Chromosomal sharing in atypical cases of gelatinous drop-like corneal dystrophy.

Authors:  Motokazu Tsujikawa; Naoyuki Maeda; Kaoru Tsujikawa; Yuichi Hori; Tomoyuki Inoue; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

7.  A unique TGFBI protein in granular corneal dystrophy types 1 and 2.

Authors:  Yu-Ping Han; Austin J Sim; Smita C Vora; Andrew J W Huang
Journal:  Curr Eye Res       Date:  2012-06-29       Impact factor: 2.424

Review 8.  Medical applications of transforming growth factor-beta.

Authors:  Kathleen C Flanders; James K Burmester
Journal:  Clin Med Res       Date:  2003-01

9.  Rapid genotyping for most common TGFBI mutations with real-time polymerase chain reaction.

Authors:  Shigeo Yoshida; Yoko Yamaji; Ayako Yoshida; Yoshihiro Noda; Yuji Kumano; Tatsuro Ishibashi
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

Review 10.  Analysis of TGFBI gene mutations in Chinese patients with corneal dystrophies and review of the literature.

Authors:  Juhua Yang; Xiaoli Han; Dinggou Huang; Lin Yu; Yihua Zhu; Yi Tong; Binliang Zhu; Chuanbao Li; Mingshe Weng; Xu Ma
Journal:  Mol Vis       Date:  2010-06-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.